SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-016515
Filing Date
2019-05-07
Accepted
2019-05-07 16:16:19
Documents
50
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kura-10q_20190331.htm 10-Q 1582895
2 EX-31.1 kura-ex311_10.htm EX-31.1 17448
3 EX-31.2 kura-ex312_6.htm EX-31.2 17256
4 EX-32.1 kura-ex321_8.htm EX-32.1 9544
  Complete submission text file 0001564590-19-016515.txt   4874040

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT kura-20190331.xml EX-101.INS 1044730
6 XBRL TAXONOMY EXTENSION SCHEMA kura-20190331.xsd EX-101.SCH 38041
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kura-20190331_cal.xml EX-101.CAL 38822
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kura-20190331_def.xml EX-101.DEF 94664
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20190331_lab.xml EX-101.LAB 245179
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20190331_pre.xml EX-101.PRE 187988
Mailing Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121
Business Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37620 | Film No.: 19803329
SIC: 2834 Pharmaceutical Preparations